Trial intelligence / Profile preview

Letrozole added to gonadotropin in assisted reproductive techniques

IRCT20110509006420N19Phase 2Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Aug 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of letrozole and relugolix in female infertility (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Chemical pregnancy rate and Clinical pregnancy rate. Started Aug 2018; status: completed.

02

Drugs

letrozolerelugolix
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT20110509006420N19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20110509006420N19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call